← SynDRA
RWJ-67657
SynDRA canonical compound SYN0005854 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | IL1B | MAPK14 | PTGS2 | TNF |
| Mechanism of action | MAP kinase inhibitor |
All known targets
- MAPK14
- PTGS2
- IL1B
- MAPK11
- TNF
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- MAPK11 INHIBITOR
- MAP kinase p38 beta inhibitor
- MEK inhibitor
- PTGS2 INHIBITOR
Cross-references
Synonyms
- JNJ-3026582
- JNJ3026582
- RWJ67657
- RWJ 67657
- 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol
- CHEMBL190333
- 4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)but-3-yn-1-ol
- 4-(4-Fluorophenyl)-2-(4-hydroxy-1-butynyl)-1-(3-Phenylpropyl)-5-(4-Pyridyl)imidazole
- 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridyl)imidazol-2-yl]but-3-yn-1-ol
- 4-(4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl)-3-butyn-1-ol
- MXN26D3ZUN
- JNJ 3026582
- RefChem:180392
- DTXCID4098358
- C27H24FN3O
- QSUSKMBNZQHHPA-UHFFFAOYSA-N
- MFCD11840606
- UNII-MXN26D3ZUN
- SCHEMBL162010
- orb1307766
- HMS3244I11
- HMS3244I12
- HMS3244J11
- EX-A9342
- BDBM50295553
- HB1300
- AKOS024457373
- NCGC00241112-01
- NCGC00241112-03
- NCGC00241112-05
- AS-16227
- FJ102876
- HY-15505
- RX-3117?
- DB-066547
- CS-0006825
- G13770
- T16812
- BRD-K07074923-001-01-5
Look up RWJ-67657 in the interactive SynDRA portal →